Azacitidine Eureco-Pharma 25 mg/ml
As listed in the register: Azacitidine Eureco-Pharma 25 mg/ml, poeder voor suspensie voor injectie
25 mg/ml · poeder voor suspensie voor injectie
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Azacitidine
- Made by
- Eureco-Pharma B.V.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (ONUREG). It describes the substance, not this exact product.
Azacitidine is a pyrimidine nucleoside analog of cytidine that inhibits DNA/RNA methyltransferases.
Azacitidine is incorporated into DNA and RNA following cellular uptake and enzymatic biotransformation to nucleotide triphosphates.
Effect of Food A high-fat, high-calorie meal (approximately 800 to 1000 calories, 50% fat) did not affect AUC 0-INF and decreased C max by 21%.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-06-12
Safety of the active substance
From the US prescribing label for the same active substance (ONUREG). It describes the substance, not this exact product.
- ONUREG is contraindicated in patients with known severe hypersensitivity to azacitidine or its components [see Adverse Reactions (6.2), Description (11) ].
- History of severe hypersensitivity to azacitidine or its components ( 4 ).
The most common adverse reactions (≥ 10%) are nausea, vomiting, diarrhea, fatigue/asthenia, constipation, upper respiratory tract infection, pneumonia, abdominal pain, arthralgia, decreased appetite, febrile neutropenia, dizziness, skin infection, and pain in extremity.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
Spain18 matching products
- AZACITIDINA ACCORD 25 mg/ml · polvo para suspensión inyectable
- AZACITIDINA BETAPHARM 25 mg/ml · polvo para suspensión inyectable
- AZACITIDINA DR. REDDYS 25 mg/ml · polvo para suspensión inyectable
- AZACITIDINA EUGIA 25 mg/ml · polvo para suspensión inyectable
- AZACITIDINA EVER PHARMA 25 mg/ml · polvo para suspensión inyectable
- AZACITIDINA GLENMARK 25 mg/ml · polvo para suspensión inyectable
- AZACITIDINA HIKMA 25 mg/ml · polvo para suspensión inyectable
- AZACITIDINA KABI 25 mg/ml · polvo para suspensión inyectable
France7 matching products
- AZACITIDINE ACCORD 25 mg · poudre pour suspension injectable
- AZACITIDINE ARROW 25 mg · poudre pour suspension injectable
- AZACITIDINE BETAPHARM 25 mg · poudre pour suspension injectable
- AZACITIDINE MYLAN 25 mg · poudre pour suspension injectable
- AZACITIDINE TILLOMED 25 mg · poudre pour suspension injectable
- AZACITIDINE ZENTIVA 25 mg · poudre pour suspension injectable
- VIDAZA 25 mg · poudre pour suspension injectable
CanadaNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Eureco-Pharma B.V. |
|---|---|
| Active substance | Azacitidine |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 25 mg/ml |
| Form | poeder voor suspensie voor injectie |
| Classification | L01BC07 · Cancer treatments and immune-system medicines |
| Route | subcutaan gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| Name in the register | Azacitidine Eureco-Pharma 25 mg/ml, poeder voor suspensie voor injectie |
| RVG | 129668//124385 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.